Related Experiment Video
Updated: May 27, 2026

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions
Published on: January 7, 2019
Adult cardiac-derived stem cells: differentiation and survival regulators
1Department of Patriotic Cardiology, Tokyo Women’s Medical University, Tokyo, Japan.
Insights
Researchers identified transforming growth factor-beta (TGF-β) as crucial for regulating cardiac stem cell differentiation. This finding advances understanding of heart failure treatments by controlling cell fate towards muscle or fat cells.
Area of Science:
- Cardiovascular Biology
- Stem Cell Research
- Regenerative Medicine
Background:
- Heart failure presents a significant global health challenge.
- Understanding cardiac stem cell biology is vital for developing effective treatments.
- Previous research has identified c-kit-positive cardiac stem cells in adult rats.
Purpose of the Study:
- To characterize cardiac stem cells and their differentiation potential.
- To identify key molecular regulators of stem cell differentiation in the heart.
- To explore the role of transforming growth factor-beta (TGF-β) in regulating cardiac cell fate.
Main Methods:
- Isolation and characterization of c-kit-positive cardiac stem cells from adult rats.
- Establishment of left atrium-derived pluripotent cells.
- Differentiation assays in methylcellulose-based Methocult medium.
- Microarray and signaling pathway analyses to identify key regulatory molecules.
Main Results:
- Left atrium-derived pluripotent cells achieved nearly 100% purity in differentiation.
- Transforming growth factor-beta (TGF-β) was identified as a key regulator of differentiation.
- TGF-β1 dose-dependently inhibited adipogenesis while activating myogenesis.
- The effect of TGF-β on differentiation is dependent on developmental stage, dosage, and timing.
Conclusions:
- Transforming growth factor-beta (TGF-β) plays a critical role in switching cardiac stem cell differentiation pathways.
- This discovery provides insights into controlling cardiac cell fate for potential heart failure therapies.
- Further research is needed to optimize TGF-β treatment parameters for therapeutic applications.
Abstract:
At present, heart failure is one of the most concerning diseases worldwide. To develop efficient treatments, it is necessary to gain a better understanding of the biological characteristics of stem cells in the heart. We recently established and characterized c-kit-positive cardiac stem cells obtained from adult rats. Moreover, we established left atrium-derived pluripotent cells that can differentiate either into skeletal/cardiac myocytes or adipocytes in a methylcellulose-based Methocult medium with almost 100% purity. Microarray and signaling pathway analyses showed that transforming growth factor (TGF)-β is a key molecule in the regulation of the differentiation switch. Indeed, TGF-β1 simultaneously inhibits adipogenesis and activates myogenesis in a dose-dependent manner. However, the effect of TGF-β varies with the developmental stage, dosage, and timing of the treatment.
Related Concept Videos
Stem Cell Culture
Regulation of Hematopoietic Stem Cells
Multipotency of Hematopoietic Stem Cells
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
iPS Cell Differentiation
Mesenchymal Stem Cells

